NASDAQ · VYGR

Voyager Therapeutics, Inc.

Closing price · Nov 13, 2026 $1.73

Latest quarter · ended Sep 30, 2026

Sales slipped and cash got weaker

descriptionFiled Nov 5, 2026
Revenue growthShrinking
−70.0%
Quarter ended Dec 31, 2024: −93.0% sales vs. a year beforeQuarter ended Mar 31, 2025: −66.8% sales vs. a year beforeQuarter ended Jun 30, 2025: −82.4% sales vs. a year beforeQuarter ended Sep 30, 2025: −45.7% sales vs. a year beforeQuarter ended Dec 31, 2025: +144.3% sales vs. a year beforeQuarter ended Mar 31, 2026: −59.9% sales vs. a year beforeQuarter ended Jun 30, 2026: −39.1% sales vs. a year beforeQuarter ended Sep 30, 2026: −70.0% sales vs. a year before
Dec '24Sep '26
$4.01M vs. $13.4M a year ago
Cash from operationsBetter
−$19.7M
Quarter ended Dec 31, 2024: −$14.5M cash from operationsQuarter ended Mar 31, 2025: −$37.9M cash from operationsQuarter ended Jun 30, 2025: −$33.3M cash from operationsQuarter ended Sep 30, 2025: −$31M cash from operationsQuarter ended Dec 31, 2025: −$30.3M cash from operationsQuarter ended Mar 31, 2026: −$33.4M cash from operationsQuarter ended Jun 30, 2026: −$25.8M cash from operationsQuarter ended Sep 30, 2026: −$19.7M cash from operations
Dec '24Sep '26
vs. −$31M a year ago
Share countDiluting
+11.9%
Quarter ended Dec 31, 2024: 55.21M sharesQuarter ended Mar 31, 2025: 55.34M sharesQuarter ended Jun 30, 2025: 55.47M sharesQuarter ended Sep 30, 2025: 55.6M sharesQuarter ended Dec 31, 2025: 59.6M sharesQuarter ended Mar 31, 2026: 60.42M sharesQuarter ended Jun 30, 2026: 61.62M sharesQuarter ended Sep 30, 2026: 62.23M shares
Dec '24Sep '26
62.23M shares vs. 55.6M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 −30
  • account_balance
    1 fund bought, 4 sold in the quarter ended Jun 30, 2026, counting funds that hold 500 stocks or fewer and $1M+ of this one. Index funds and banks are left out.
  • info
    3 real insider sales in 12 months. $77.2K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

140 funds report owning VYGR, up from 136

Holdings as of Jun 30, 2026
New22
Added56
Held31
Trimmed31
Sold out18

Last quarter

Who bought and who sold

Apr–Jun 2026
Vestal Point Capital, LP
−13%
Opaleye Management Inc.
+3%
Sphera Funds Management Ltd.
−9%
Diadema Partners LP
−2%
Altshuler Shaham Ltd
−48%

Change in shares held from Mar 31 to Jun 30, 2026, biggest holdings first. Only funds that hold 500 stocks or fewer and $1M+ of this one: index funds and banks own almost everything, so their changes say little. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Feb 6 · 123,000 sh · 3 peopleStock grant · Feb 6 · 32,250 shStock grant · Feb 6 · 86,250 shPlanned sale (10b5-1) · Feb 18 · $24.7K · 2 peoplePlanned sale (10b5-1) · Feb 18 · $40KPlanned sale (10b5-1) · Feb 24 · $40K · 2 peoplePlanned sale (10b5-1) · Feb 24 · $17.6KPlanned sale (10b5-1) · Feb 24 · $53.8KStock grant · Apr 1 · 50,000 shPlanned sale (10b5-1) · Apr 2 · $44.5KStock grant · Nov 1 · 101,250 sh · 2 peopleOpen-market sale · Feb 10 · $31.2K · 2 peopleOpen-market sale · Feb 10 · $46.1K
CEOCFOOther officersDirectorsDecFebAprJunAugOctStock grant · Feb 6 · 123,000 sh · 3 peopleStock grant · Feb 6 · 32,250 shStock grant · Feb 6 · 86,250 shPlanned sale (10b5-1) · Feb 18 · $24.7K · 2 peoplePlanned sale (10b5-1) · Feb 18 · $40KPlanned sale (10b5-1) · Feb 24 · $40K · 2 peoplePlanned sale (10b5-1) · Feb 24 · $17.6KPlanned sale (10b5-1) · Feb 24 · $53.8KStock grant · Apr 1 · 50,000 shPlanned sale (10b5-1) · Apr 2 · $44.5KStock grant · Nov 1 · 101,250 sh · 2 peopleOpen-market sale · Feb 10 · $31.2K · 2 peopleOpen-market sale · Feb 10 · $46.1K

Last 12 months. No real trades in the last 6.

Showing 3 real trades. Hidden: 8 stock grants, 8 planned 10b5-1 sales. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Feb 10 Alfred Sandrock President and CEO, Director Open-market sale $46.1K 12,192 sh at $3.78 Sold 2% of stake
Feb 10 Robin Swartz COO & CBO Open-market sale $17.6K 4,569 sh at $3.85 Sold 2% of stake
Feb 10 Todd Carter Chief Scientific Officer Open-market sale $13.6K 3,525 sh at $3.85 Sold 2% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in VYGR

As of Jun 30, 2026
FundOwnsValueChange
BlackRock, Inc.8.3%$18.1M−7%
Millennium Management LLC7.1%$15.6M+30%
Armistice Capital, LLC5.5%$12M−2%
Vestal Point Capital, LP4.2%$9.19M−13%
Vanguard Capital Management LLC3.8%$8.21M+3%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist